Quick ratio společnosti Akari Therapeutics Plc

Jaká je hodnota metriky Quick ratio společnosti Akari Therapeutics Plc?

Hodnota metriky Quick ratio společnosti Akari Therapeutics Plc je 2.68

Jaká je definice metriky Quick ratio?



Quick ratio je ukazatel likvidity, který měří schopnost společnosti využít své jmění na pokrytí krátkodobých závazků.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Akari Therapeutics Plc

Čemu se věnuje společnost Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Firmy s metrikou quick ratio podobnou společnosti Akari Therapeutics Plc